Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.23.3
Stockholders' Equity (Tables)
 9 Months Ended
Sep. 30, 2023
Stockholders' Equity [Abstract]  
Schedule of Warrant and Stock Option Grants with Time-Based Vesting The number of shares of the Company’s common stock that are issuable pursuant to warrant and stock option grants with time-based vesting as of and for the nine months ended September 30, 2023 were:
    Warrant Grants       Stock Option Grants       Restricted
Stock Units		  
    Number of
shares
subject to
warrants		       Weighted-
average
exercise
price per
share		       Number of
shares
subject to
options		       Weighted-
average
exercise
price per
share		       Number of
shares
subject to
restricted
stock units		  
Balance at December 31, 2022   1,567,720     $ 1.35       118,388     $ 3.25       2,409,759  
Granted  
-
      
-
      
-
      
-
       871,568  
Exercised   (823,078 )     0.65      
-
      
-
       (715,574 )
Cancelled/Expired   (72,180 )     8.05       (18,388 )     6.57       (69,166 )
Balance at September 30, 2023   672,462     $ 1.48       100,000     $ 2.64       2,496,587  
Exercisable at September 30, 2023   672,462     $ 1.48       100,000     $ 2.64       2,439,087  
Schedule of Company’s Outstanding Warrants and Options The Company’s outstanding warrants and options at September 30, 2023 are as follows:
Warrants Outstanding     Warrants Exercisable  
Exercise Price
Range		     Number
Outstanding		       Weighted Average
Remaining
Contractual Life
(in years)		       Weighted 
Average
Exercise 
Price		     Number
Exercisable		     Weighted
Average
Exercise Price		       Intrinsic Value  
$0.65 - $4.00     672,462       0.64     $ 1.48     672,462   $ 1.48      
-
  
Options Outstanding   Options Exercisable
Exercise Price
Range		   Number
Outstanding		     Weighted Average
Remaining
Contractual Life
(in years)		     Weighted
Average
Exercise
Price		     Number
Exercisable		   Weighted
Average
Exercise Price		     Intrinsic Value  
$2.64     100,000       1.16     $ 2.64     100,000   $ 2.64      
-
  
Schedule of Stock-Based Compensation Expense Stock-based compensation expense for three and nine months ended September 30, 2023 and 2022 was as follows:
    For the three months ended     For the nine months ended  
    September 30,     September 30,  
    2023     2022     2023     2022  
Stock-based compensation expense   $ 40,547     $ 261,370     $ 336,293     $ 906,919  
Schedule of Stock-Based Compensation Expense Categorized By the Equity Components Stock-based compensation expense categorized by the equity components for three and nine months ended September 30, 2023 and 2022 was as follows:
    For the three months ended     For the nine months ended  
    September 30,     September 30,  
    2023     2022     2023     2022  
Common stock   $ 40,547     $ 261,370     $ 336,293     $ 906,919  
Total   $ 40,547     $ 261,370     $ 336,293     $ 906,919